Alfredo Ponce‐de‐León

Author

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán ORCID

Also Known As

A Léon, A PONCE de LEON, A Ponce de Leon, A Ponce de León, A Ponce-de-Leon, A Ponce-de-León, A Ponce-de-León Garduño, A Ponce-de-León-Garduño, A. Leon, A. León

292

Publications

26K

Citations

H-Index

103

Concepts

All Affiliations

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Instituto Nacional de Salud Pública Universidad Nacional Autónoma de México Stanford University Instituto Nacional de Enfermedades Respiratorias

About

Alfredo Ponce‐de‐León is an author at Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán specializing in medicine, clinical microbiology, and tuberculosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	29	4.7K
2	Health Sciences	8	8	669
3	Public Health	7	7	2.5K
4	Engineering	1	1	15
5	Allergy	1	1	26

Alfredo Ponce‐de‐León

124

Publications

9.7K

Citations

H-Index

Page 1

	Year	Citations
Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050 Mohsen Naghavi, Kevin S Ikuta, Lucien R Swetschinski, The Lancet Global BurdenAntimicrobial SusceptibilityAntimicrobial StewardshipAntibioticsMedicine	2024	2.2K
Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli MA Behr, S. H. Warren, Hugh Salamon, The Lancet Medical MicrobiologyPulmonary TuberculosisMycobacterium TuberculosisTuberculosisMicrobiology	1999	759
Global Phylogeny of<i>Mycobacterium tuberculosis</i>Based on Single Nucleotide Polymorphism (SNP) Analysis: Insights into Tuberculosis Evolution, Phylogenetic Accuracy of Other DNA Fingerprinting Systems, and Recommendations for a Minimal Standard SNP Set Ingrid Filliol, Alifiya S. Motiwala, Magali Cavatore, Journal of Bacteriology	2005	434
Population Genetics Study of Isoniazid Resistance Mutations and Evolution of Multidrug-Resistant <i>Mycobacterium tuberculosis</i> Manzour Hernando Hazbón, Michael Brimacombe, Miriam Bobadilla-del-Valle, Antimicrobial Agents and Chemotherapy Isoniazid Resistance MutationsGeneticsTuberculosis PreventionAntibiotic ResistanceDrug Resistance	2006	383
Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes María Eugenia Jiménez-Corona, Luis Pablo Cruz‐Hervert, Lourdes García‐García, Thorax	2012	291
Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial Johan Maertens, Galia Rahav, Dong‐Gun Lee, The Lancet Invasive AspergillosisPosaconazole Versus VoriconazoleAntifungal AgentAntifungal AgentsMedicinal Fungi	2021	257
Tuberculosis and Diabetes in Southern Mexico Alfredo Ponce‐de‐León, Lourdes García‐García, Ma. Cecilia García-Sancho, Diabetes Care	2004	246
B Cell Subsets as Severity-Associated Signatures in COVID-19 Patients Víctor A. Sosa‐Hernández, Jiram Torres‐Ruiz, Rodrigo Cervantes‐Díaz, Frontiers in Immunology	2020	158
In-hospital mortality from severe COVID-19 in a tertiary care center in Mexico City; causes of death, risk factors and the impact of hospital saturation Antonio Olivas‐Martínez, José Luis Cárdenas-Fragoso, José Víctor Jiménez, PLoS ONE	2021	146
Metabolomics analysis reveals a modified amino acid metabolism that correlates with altered oxygen homeostasis in COVID-19 patients José C. Páez-Franco, Jiram Torres‐Ruiz, Víctor A. Sosa‐Hernández, Scientific Reports	2021	138

Page 1